# Anaptysbio, Inc: Form 8-K, filed Jan 9, 2026

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: 8-K
- Filed: 2026-01-09
- Accepted by EDGAR: Jan 9, 2026, 22:17 ET
- Period: 2026-01-09
- Accession: 0001370053-26-000002
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/anab-20260109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/anab-20260109.htm

Filed Jan 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001370053-26-000002. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.